1-(2,6-diphenylphenyl)-3-[3-(3-methyl-2H-benzimidazol-1-yl)-5-(trifluoromethyl)phenyl]-2H-benzimidazole
C40H31F3N4 — CID 177105719
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(2,6-diphenylphenyl)-3-[3-(3-methyl-2H-benzimidazol-1-yl)-5-(trifluoromethyl)phenyl]-2H-benzimidazole
1-(2,6-diphenylphenyl)-3-[3-(3-methyl-2H-benzimidazol-1-yl)-5-(trifluoromethyl)phenyl]-2H-benzimidazole (PubChem CID 177105719) has the molecular formula C40H31F3N4 and a molecular weight of 624.71 g/mol. Its IUPAC name is 1-(2,6-diphenylphenyl)-3-[3-(3-methyl-2H-benzimidazol-1-yl)-5-(trifluoromethyl)phenyl]-2H-benzimidazole.
Molecular Properties
| Compound Name | 1-(2,6-diphenylphenyl)-3-[3-(3-methyl-2H-benzimidazol-1-yl)-5-(trifluoromethyl)phenyl]-2H-benzimidazole |
|---|---|
| PubChem CID | 177105719 |
| Molecular Formula | C40H31F3N4 |
| Molecular Weight | 624.71 g/mol |
| Exact Mass | 624.25 |
| IUPAC Name | 1-(2,6-diphenylphenyl)-3-[3-(3-methyl-2H-benzimidazol-1-yl)-5-(trifluoromethyl)phenyl]-2H-benzimidazole |
| SMILES | CN1CN(c2cc(N3CN(c4c(-c5ccccc5)cccc4-c4ccccc4)c4ccccc43)cc(C(F)(F)F)c2)c2ccccc21 |
| InChI | InChI=1S/C40H31F3N4/c1-44-26-45(36-20-9-8-19-35(36)44)31-23-30(40(41,42)43)24-32(25-31)46-27-47(38-22-11-10-21-37(38)46)39-33(28-13-4-2-5-14-28)17-12-18-34(39)29-15-6-3-7-16-29/h2-25H,26-27H2,1H3 |
| InChIKey | YVAJCMGKDVPFNG-UHFFFAOYSA-N |
| XLogP | 10.83 |
| TPSA | 12.96 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 624.71 |
| LogP ≤ 5 | 10.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177105719 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.